SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Bhutia SK, Das SK, Azab B, Dash R, Su ZZ, Lee SG, Dent P, Curiel DT, Sarkar D, Fisher PB. 2011. Autophagy switches to apoptosis in prostate cancer cells infected with melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24). Autophagy 9: 10761077.
  • Catasús L, Llorente-Cortés V, Cuatrecasas M, Pons C, Espinosa I, Prat J. 2011. Low-density lipoprotein receptor-related protein 1 (LRP-1) is associated with high grade, advanced stage and p53 and p16 alterations in endometrial carcinomas. Histopathology 3: 567571.
  • Chang S, Chen W, Yang J, Xie Y, Sheng W. 2009. Antitumor activity of an adenovirus harboring two therapeutic genes, anti-VEGF ribozyme and human IL-24, in colon cancer. Mol Med Report 5: 693700.
  • Cheng J, Wang J, Chen B, Xia G, Cai X, Liu R, Ren Y, Bao W, Wang X. 2011. A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. Int J Nanomed 6: 21232131.
  • Dent P, Yacoub A, Hamed HA, Park MA, Dash R, Bhutia SK, Sarkar D, Wang XY, Gupta P, Emdad L, Lebedeva IV, Sauane M, Su ZZ, Rahmani M, Broaddus WC, Young HF, Lesniak MS, Grant S, Curiel DT, Fisher PB. 2010. The development of MDA-7/IL-24 as a cancer therapeutic. Pharmacol Ther 2: 375384.
  • Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC. 2001. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167: 35453549.
  • Emdad L, Lebedeva IV, Su ZZ, Sarkar D, Dent P, Curiel DT, Fisher PB. 2007. Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells. Mol Cancer Ther 6: 29852994.
  • Haimeur A, Conseil G, Deeley RG, Cole SP. 2004. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5: 2153.
  • Kanagasabai R, Krishnamurthy K, Druhan LJ, Ilangovan G. 2011. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells. J Biol Chem 38: 3328933300.
  • Loo TW, Bartlett MC, Shi L, Clarke DM. 2012. Corrector-mediated rescue of misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pump. Biochem Pharmacol 3: 345354.
  • Lu D, Shi HC, Wang ZX, Gu XW, Zeng YJ. 2011. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma. Br J Biomed Sci 2: 6974.
  • Otkjaer K, Holtmann H, Kragstrup TW, Paludan SR, Johansen C, Gaestel M, Kragballe K, Iversen L. 2010. The p38 MAPK regulates IL-24 expression by stabilization of the 3′ UTR of IL-24 mRNA. PLoS One 1: e8671.
  • Navarro G, Sawant RR, Biswas S, Essex S, Tros de Ilarduya C, Torchilin VP. 2012. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells. Nanomedicine (Lond) 1: 6578.
  • Valero VIII, Wingate H, Chada S, Liu Y, Palalon F, Mills G, Keyomarsi K, Hunt KK. 2011. MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells. Cancer Gene Ther 7: 510519.
  • Wang H, Wang X, Li Y, Liao A, Fu B, Pan H, Liu Z, Yang W. 2012. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-κB pathway. Pharmazie 2:187192.
  • Wang CJ, Zhang H, Chen K, Zheng JW, Xiao CW, Ji WW, Yu Y, Hu HY, Li Y, Xue XB. 2010. Ad.mda-7 (IL-24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumors. Oncol Res 11–12: 561574.
  • Wang X, Ye Z, Zhong J, Xiang J, Yang J. 2007. Adenovirus-mediated Il-24 expression suppresses hepatocellular carcinoma growth via induction of cell apoptosis and cycling arrest and reduction of angiogenesis. Cancer Biother Radiopharm 22: 5663.
  • Wei N, Fan JK, Gu JF, Liu XY. 2010. Double-regulated oncolytic adenovirus-mediated interleukin-24 overexpression exhibits potent antitumor activity on gastric adenocarcinoma. Hum Gene Ther 21: 855864.
  • Xiao CW, Xue XB, Zhang H, Gao W, Yu Y, Chen K, Zheng JW, Wang CJ. 2010. Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines. Hepatobiliary Pancreat Dis Int 6: 615621.
  • Xu Y, Zheng H, Kang JS, Zhang L, Su J, Li HY, Sun LK. 2011. 5-Nitro-2-(3-phenylpropylamino) benzoic acid induced drug resistance to cisplatin in human erythroleukemia cell lines. Anat Rec (Hoboken) 6: 945952.
  • Yang BX, Duan YJ, Dong CY, Zhang F, Gao WF, Cui XY, Lin YM, Ma XT. 2011. Novel functions for mda-7/IL-24 and IL-24 delE5: regulation of differentiation of acute myeloid leukemic cells. Mol Cancer Ther 4: 615625.
  • Zhang BF, Liu JJ, Pei DS, Yang ZX, Di JH, Chen FF, Li HZ, Xu W, Wu YP, Zheng JN. 2011a. Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells. Cancer Biother Radiopharm 5: 647655.
  • Zhang R, Zhang Z, Pan X, Huang X, Huang Z, Zhang G. 2011b. ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721. Anat Rec (Hoboken) 3: 406411.
  • Zhu WY, Hunag YY, Liu XG, He JY, Chen DD, Zeng F, Zhou JH, Zhang YK. 2012. Prognostic evaluation of CapG, Gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer. Anat Rec 2: 208214.